146 related articles for article (PubMed ID: 35718359)
1. X-Linked Kidney Disorders in Women.
Quinlan C; Rheault MN
Semin Nephrol; 2022 Mar; 42(2):114-121. PubMed ID: 35718359
[TBL] [Abstract][Full Text] [Related]
2. X inactivation, female mosaicism, and sex differences in renal diseases.
Migeon BR
J Am Soc Nephrol; 2008 Nov; 19(11):2052-9. PubMed ID: 18448583
[TBL] [Abstract][Full Text] [Related]
3. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
Morin D
Nephrol Ther; 2014 Dec; 10(7):538-46. PubMed ID: 25449762
[TBL] [Abstract][Full Text] [Related]
4. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study.
Jais JP; Knebelmann B; Giatras I; De Marchi M; Rizzoni G; Renieri A; Weber M; Gross O; Netzer KO; Flinter F; Pirson Y; Dahan K; Wieslander J; Persson U; Tryggvason K; Martin P; Hertz JM; Schröder C; Sanak M; Carvalho MF; Saus J; Antignac C; Smeets H; Gubler MC
J Am Soc Nephrol; 2003 Oct; 14(10):2603-10. PubMed ID: 14514738
[TBL] [Abstract][Full Text] [Related]
5. A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.
Schernthaner-Reiter MH; Adams D; Trivellin G; Ramnitz MS; Raygada M; Golas G; Faucz FR; Nilsson O; Nella AA; Dileepan K; Lodish M; Lee P; Tifft C; Markello T; Gahl W; Stratakis CA
Eur J Pediatr; 2016 May; 175(5):727-33. PubMed ID: 26795631
[TBL] [Abstract][Full Text] [Related]
6. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
7. X-linked Alport syndrome caused by splicing mutations in COL4A5.
Nozu K; Vorechovsky I; Kaito H; Fu XJ; Nakanishi K; Hashimura Y; Hashimoto F; Kamei K; Ito S; Kaku Y; Imasawa T; Ushijima K; Shimizu J; Makita Y; Konomoto T; Yoshikawa N; Iijima K
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1958-64. PubMed ID: 25183659
[TBL] [Abstract][Full Text] [Related]
8. Correlation between clinical phenotypes and X-inactivation patterns in six female carriers with heterozygote vasopressin type 2 receptor gene mutations.
Satoh M; Ogikubo S; Yoshizawa-Ogasawara A
Endocr J; 2008 May; 55(2):277-84. PubMed ID: 18323675
[TBL] [Abstract][Full Text] [Related]
9. Comparison of alpha5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome.
Nakanishi K; Iijima K; Kuroda N; Inoue Y; Sado Y; Nakamura H; Yoshikawa N
J Am Soc Nephrol; 1998 Aug; 9(8):1433-40. PubMed ID: 9697665
[TBL] [Abstract][Full Text] [Related]
10. X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome.
Rheault MN; Kren SM; Hartich LA; Wall M; Thomas W; Mesa HA; Avner P; Lees GE; Kashtan CE; Segal Y
Nephrol Dial Transplant; 2010 Mar; 25(3):764-9. PubMed ID: 19854849
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic heterogeneity in females with X-linked Alport syndrome.
Allred SC; Weck KE; Gasim A; Mottl AK
Clin Nephrol; 2015 Nov; 84(5):296-300. PubMed ID: 26249550
[TBL] [Abstract][Full Text] [Related]
12. X Chromosome Inactivation in Carriers of Fabry Disease: Review and Meta-Analysis.
Viggiano E; Politano L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299283
[TBL] [Abstract][Full Text] [Related]
13. GENETICS IN ENDOCRINOLOGY Pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus.
Bichet DG
Eur J Endocrinol; 2020 Aug; 183(2):R29-R40. PubMed ID: 32580146
[TBL] [Abstract][Full Text] [Related]
14. A novel deletion mutation in the arginine vasopressin receptor 2 gene and skewed X chromosome inactivation in a female patient with congenital nephrogenic diabetes insipidus.
Kinoshita K; Miura Y; Nagasaki H; Murase T; Bando Y; Oiso Y
J Endocrinol Invest; 2004 Feb; 27(2):167-70. PubMed ID: 15129813
[TBL] [Abstract][Full Text] [Related]
15. [Hereditary nephrogenic diabetes insipidus].
Morin D; Ala Y; Dumas R
Arch Pediatr; 1995 Jun; 2(6):560-7. PubMed ID: 7640759
[TBL] [Abstract][Full Text] [Related]
16. Fabry disease and nephrogenic diabetes insipidus.
Wornell P; Dyack S; Crocker J; Yu W; Acott P
Pediatr Nephrol; 2006 Aug; 21(8):1185-8. PubMed ID: 16721592
[TBL] [Abstract][Full Text] [Related]
17. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
Bichet DG; Bockenhauer D
Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cellular defects in nephrogenic diabetes insipidus.
Knoers NV; van Os CH
Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):353-8. PubMed ID: 8823534
[TBL] [Abstract][Full Text] [Related]
19. Female X-linked Alport syndrome with somatic mosaicism.
Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
[TBL] [Abstract][Full Text] [Related]
20. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation.
van Lieburg AF; Verdijk MA; Schoute F; Ligtenberg MJ; van Oost BA; Waldhauser F; Dobner M; Monnens LA; Knoers NV
Hum Genet; 1995 Jul; 96(1):70-8. PubMed ID: 7607658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
